Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meridia for Long-Term Weight Loss in Obese Subjects
NCT00645255Phase 3Terminated
- Sponsor
- Abbott Laboratories
- Start
- Sep 1998
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of sibutramine in obesity, sponsored by Abbott Laboratories. Started Sep 1998; status: terminated.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00645255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645255.